Quince Therapeutics, Inc. Active Patents
9 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-05-09: Application 17740260; Invention KETONE INHIBITORS OF LYSINE GINGIPAIN; Applicant CORTEXYME, INC.; Status Patented Case.
- 2020-10-29: Application 17083771; Invention PROCESS FOR THE PREPARATION OF ERYTHROCYTES LOADED WITH ONE OR MORE SUBSTANCES OF PHARMACEUTICAL INTEREST AND SO OBTAINED ERYTHROCYTES; Applicant QUINCE THERAPEUTICS S.P.A.; Status Patented Case.
- 2020-06-11: Application 16899376; Invention KETONE INHIBITORS OF LYSINE GINGIPAIN; Applicant CORTEXYME, INC.; Status Patented Case.
- 2020-05-04: Application 16866022; Invention INHIBITORS OF LYSINE GINGIPAIN; Applicant Cortexyme, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-09 | 17740260 | KETONE INHIBITORS OF LYSINE GINGIPAIN | CORTEXYME, INC. | Patented Case | 2024-10-08 | 12110263 | US20230142714A1 | Andrei W. Konradi Robert A. Galemmo JR. Stephen S. Dominy Casey C. Lynch Leslie J. Holsinger | United States United States United States United States United States | HABTE, KAHSAY |
| 2020-10-29 | 17083771 | PROCESS FOR THE PREPARATION OF ERYTHROCYTES LOADED WITH ONE OR MORE SUBSTANCES OF PHARMACEUTICAL INTEREST AND SO OBTAINED ERYTHROCYTES | QUINCE THERAPEUTICS S.P.A. | Patented Case | 2025-05-27 | 12311059 | US20210283063A1 | Giovanni MAMBRINI Luca Benatti Giovanni Capogrossi Marco Mandolini | Italy Italy Italy Italy | POPA, ILEANA |
| 2020-06-11 | 16899376 | KETONE INHIBITORS OF LYSINE GINGIPAIN | CORTEXYME, INC. | Patented Case | 2022-05-10 | 11325884 | US20210053908A1 | Andrei W. Konradi Robert A. Galemmo JR. Stephen S. Dominy Casey C. Lynch Leslie J. Holsinger | United States United States United States United States United States | HABTE, KAHSAY |
| 2020-05-04 | 16866022 | INHIBITORS OF LYSINE GINGIPAIN | Cortexyme, Inc. | Patented Case | 2022-05-17 | 11332464 | US20210017167A1 | Andrei W. Konradi Stephen S. Dominy Casey Crawford Lynch Craig Coburn Joseph Vacca | United States United States United States United States United States | COUGHLIN, MATTHEW P |
| 2019-11-08 | 16678700 | AMINOPYRIDINE COMPOUNDS AND METHODS FOR THE PREPARATION AND USE THEREOF | Cortexyme, Inc. | Patented Case | 2021-07-13 | 11059786 | US20200148642A1 | Andrei W. Konradi Robert A. Galemmo JR. Casey C. Lynch | United States United States United States | MAURO, JOHN MATTHEW |
| 2019-03-14 | 16353786 | KETONE INHIBITORS OF LYSINE GINGIPAIN | CORTEXYME, INC. | Patented Case | 2020-08-04 | 10730826 | US20190210960A1 | Andrei W. Konradi Robert A. Galemmo JR. Stephen S. Dominy Casey C. Lynch Leslie J. Holsinger | United States United States United States United States United States | HABTE, KAHSAY |
| 2018-06-04 | 15996660 | INHIBITORS OF LYSINE GINGIPAIN | Cortexyme, Inc. | Patented Case | 2019-05-28 | 10301301 | US20180346460A1 | Andrei Konradi Stephen S. Dominy Casey Crawford Lynch Craig Coburn Joseph Vacca | United States United States United States United States United States | COUGHLIN, MATTHEW P |
| 2017-08-22 | 15683348 | INHIBITORS OF LYSINE GINGIPAIN | Cortexyme, Inc. | Patented Case | 2018-06-05 | 9988375 | US20170349537A1 | Andrei Konradi Stephen S. Dominy Casey Crawford Lynch Craig Coburn Joseph Vacca | United States United States United States United States United States | COUGHLIN, MATTHEW P |
| 2015-10-05 | 14875416 | INHIBITORS OF LYSINE GINGIPAIN | Cortexyme, Inc. | Patented Case | 2017-09-12 | 9758473 | US20160096830A1 | Andrei KONRADI Stephen S. DOMINY Casey CRAWFORD LYNCH Craig COBURN Joseph VACCA | United States United States United States United States United States | COUGHLIN, MATTHEW P |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |